Arbet-Engels Christophe
Reporting owner on Forms 3, 4 and 5, CIK 1802615.
Arbet-Engels Christophe reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-10-05.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| Altimmune, Inc. CIK 1326190 | officer (Chief Medical Officer) | 1 | 2026-10-05 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| Altimmune, Inc. Common Stock, par value $0.0001 | 2026-10-01 | M exercised | +37,500 | $0 | 37,500 | Form 4 |
| Altimmune, Inc. Common Stock, par value $0.0001 | 2026-10-01 | F withheld for tax | -12,679 | $2.76 | 24,821 | Form 4 |
| Altimmune, Inc. Restricted Stock Units, derivative | 2026-10-01 | M exercised | -37,500 | $0 | 112,500 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001802615-26-000002 | Altimmune, Inc. | 2026-10-05 |